Northwestern Medicine scientists have discovered that specialized immune cells within the glioblastoma tumor metabolize fructose to suppress immune responses and promote tumor growth, reports a study ...

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...

Nanobodies—miniature proteins—derived from camel antibodies demonstrated powerful potential to accurately and safely deliver ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

Cancer cell-derived small extracellular vesicles (sEVs) can travel from distant tumors through the bloodstream and kidneys ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and immunoediting compared with single-pathway CAR-T constructs. Complete tumor ...

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are spending billions to bring the same technology to human patients.

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...

Scientists have engineered a common probiotic bacterium to act like a microscopic drug factory that hunts down tumors and delivers cancer-killing compounds directly where they’re needed. Credit: ...

After spending thousands on chemotherapy and surgery for little payoff, tech entrepreneur Paul Conyngham paired with an ...

A 1951 CIA report on parasites and tumors spread online in March 2026 — but it was declassified years ago and does not reveal a cancer cure.